Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

November 24, 2017

Primary Completion Date

April 16, 2019

Study Completion Date

October 12, 2019

Conditions

Rheumatoid Arthritis

Interventions

DRUG

SHR0302

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (1)

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03254966 - Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients | Biotech Hunter | Biotech Hunter